全文获取类型
收费全文 | 69718篇 |
免费 | 5118篇 |
国内免费 | 123篇 |
专业分类
耳鼻咽喉 | 608篇 |
儿科学 | 2841篇 |
妇产科学 | 1958篇 |
基础医学 | 8952篇 |
口腔科学 | 789篇 |
临床医学 | 10271篇 |
内科学 | 12121篇 |
皮肤病学 | 944篇 |
神经病学 | 6439篇 |
特种医学 | 1467篇 |
外科学 | 6752篇 |
综合类 | 853篇 |
一般理论 | 120篇 |
预防医学 | 9364篇 |
眼科学 | 1028篇 |
药学 | 4942篇 |
中国医学 | 74篇 |
肿瘤学 | 5436篇 |
出版年
2023年 | 315篇 |
2022年 | 441篇 |
2021年 | 1212篇 |
2020年 | 795篇 |
2019年 | 1241篇 |
2018年 | 1448篇 |
2017年 | 1160篇 |
2016年 | 1220篇 |
2015年 | 1444篇 |
2014年 | 1983篇 |
2013年 | 3163篇 |
2012年 | 4585篇 |
2011年 | 4878篇 |
2010年 | 2755篇 |
2009年 | 2424篇 |
2008年 | 4423篇 |
2007年 | 4698篇 |
2006年 | 4541篇 |
2005年 | 4687篇 |
2004年 | 4479篇 |
2003年 | 4244篇 |
2002年 | 3896篇 |
2001年 | 999篇 |
2000年 | 864篇 |
1999年 | 916篇 |
1998年 | 851篇 |
1997年 | 733篇 |
1996年 | 607篇 |
1995年 | 594篇 |
1994年 | 555篇 |
1993年 | 461篇 |
1992年 | 584篇 |
1991年 | 561篇 |
1990年 | 504篇 |
1989年 | 495篇 |
1988年 | 506篇 |
1987年 | 486篇 |
1986年 | 440篇 |
1985年 | 439篇 |
1984年 | 431篇 |
1983年 | 371篇 |
1982年 | 345篇 |
1981年 | 326篇 |
1980年 | 265篇 |
1979年 | 283篇 |
1978年 | 226篇 |
1977年 | 161篇 |
1976年 | 194篇 |
1974年 | 218篇 |
1973年 | 179篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
101.
102.
103.
104.
Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer. 总被引:3,自引:0,他引:3
Amit Shah William A Swain Donna Richardson John Edwards Duncan J Stewart Catherine M Richardson Daniel E B Swinson Dipika Patel J Louise Jones Kenneth J O'Byrne 《Clinical cancer research》2005,11(8):2930-2936
Akt, a Serine/Threonine protein kinase, mediates growth factor-associated cell survival. Constitutive activation of Akt (phosphorylated Akt, P-Akt) has been observed in several human cancers, including lung cancer and may be associated with poor prognosis and chemotherapy and radiotherapy resistance. The clinical relevance of P-Akt in non-small cell lung cancer (NSCLC) is not well described. In the present study, we examined 82 surgically resected snap-frozen and paraffin-embedded stage I to IIIA NSCLC samples for P-Akt and Akt by Western blotting and for P-Akt by immunohistochemistry. P-Akt protein levels above the median, measured using reproducible semiquantitative band densitometry, correlated with a favorable outcome (P = 0.007). Multivariate analysis identified P-Akt as a significant independent favorable prognostic factor (P = 0.004). Although associated with a favorable prognosis, high P-Akt levels correlated with high tumor grade (P = 0.02). Adenocarcinomas were associated with low P-Akt levels (P = 0.039). Akt was not associated with either outcome or clinicopathologic variables.Cytoplasmic (CP-Akt) and nuclear (NP-Akt) P-Akt tumor cell staining was detected in 96% and 42% of cases, respectively. Both CP-Akt and NP-Akt correlated with well-differentiated tumors (P = 0.008 and 0.017, respectively). NP-Akt also correlated with nodal metastases (P = 0.022) and squamous histology (P = 0.037).These results suggest P-Akt expression is a favorable prognostic factor in NSCLC. Immunolocalization of P-Akt, however, may be relevant as NP-Akt was associated with nodal metastases, a known poor prognostic feature in this disease. P-Akt may be a potential novel therapeutic target for the management of NSCLC. 相似文献
105.
The cases of 33 children with hypothalamic-chiasmatic gliomas are reviewed. Radiation therapy produced clinical or radiographic improvement in 11 (46%) of 24 patients. Progression was documented in 18 patients (54%). Overall, the median time to tumor progression was 60 months; it was 70 months in patients who received radiation therapy and 30 months in those who did not (P less than 0.05). Chemotherapy, either given initially or at the time of progression, caused the tumor to respond or to stabilize in 10 patients. Partial resection of the tumor led to improvement in 3 of 12 patients, obviating the need for a shunt in 2 of them; there were no deaths and postoperative morbidity was transient and minimal (diabetes insipidus, intraventricular hemorrhage, and left hemiparesis in one patient each). The 5- and 10-year survival probabilities were 93 and 74%, respectively. Patients with neurofibromatosis had a better prognosis. 相似文献
106.
107.
108.
Survival, mutagenesis, and host cell reactivation in a Chinese hamster ovary cell ERCC1 knock-out mutant 总被引:2,自引:0,他引:2
Rolig Rhonda L.; Layher Susan K.; Santi Barbara; Adair Gerald M.; Gu Feng; Rainbow Andrew J.; Nairn Rodney S. 《Mutagenesis》1997,12(4):277-283
Positive selection-negative selection gene targeting was usedto disrupt the nucleotide excision repair gene ERCC1 in a Chinesehamster ovary cell line, CHO-K1. Southern and Northern analysisshowed that a cell clone isolated by this targeting approach,CHO-7-27, had an ERCC1 gene structure consistent with targeteddisruption of ERCC1 exon V, and did not express ERCC1 mRNA.CHO-7-27 was further characterized with respect to UV and mitomycinC sensitivities, and was shown to exhibit severe mutagen sensitivityphenotypes consistent with those of other CHO cell ERCC1 mutants.Mutation frequency experiments showed that CHO-7-27 was UV-hypermutableat the hypoxanthine-guanine phosphoribosyltransferase locus.Experiments assessing host cell reactivation of viral DNA synthesisfor UV-irradiated adenovirus showed that CHO7-27 exhibited aseverely deficient HCR phenotype similar to that of UV20 cells.Our results demonstrate that CHOK1 cells are hemizygous forthe ERCC1 gene, and show that the comparatively mild mutagensensitivities and lack of severely deficient HCR phenotypesof conventionally derived CHO-K1 ERCC1 mutants, in contrastto the severe phenotypes of CHO-AA8-derived mutants, are notdue to any intrinsic genetic differences between CHO-K1 andCHO-AA8 parental cell lines.
4To whom correspondence should be addressed 相似文献
109.
110.
Effects of Ethanol in an Experimental Model of Combined Traumatic Brain Injury and Hemorrhagic Shock 总被引:3,自引:2,他引:1
Brian J. Zink MD Susan A. Stern MD Xu Wang MD Carl C. Chudnofsky MD 《Academic emergency medicine》1998,5(1):9-17
Objectives: Given that clinical and laboratory studies suggest that ethanol and hemorrhagic shock (HS) potentiate traumatic brain injury (TBI), the authors studied the effects of ethanol in a model of combined TBI and HS.
Methods: A controlled porcine model of combined TBI and HS was evaluated for the effect of ethanol on survival time, hemodynamic function, and cerebral tissue perfusion. Anesthetized swine (17–24 kg) were instrumented, splenectomized, and subjected to fluid percussion TBI with concurrent 25-mL/kg graded hemorrhage over 30 minutes. Two groups were studied: control ( n = 11) and ethanol ( n = 11). Ethanol, 3.5 g/kg intragastric, was given 100 minutes prior to TBI/HS. Systemic and cerebral physiologic and metabolic parameters were monitored for 2 hours without resuscitation. Regional cerebral blood flow (rCBF) and renal blood flow were measured with dye-labeled microspheres. Data were analyzed with 2-sample t-test and repeated-measures ANOVA.
Results: Ethanol levels at the time of injury were 162 ± 68 mg/dL. Average TBI was 2.65 ± 0.35 atm. Survival time was significantly shorter in the ethanol group (60 ± 27 min vs 94 ± 28 min, p = 0.011). The ethanol group had significantly lower mean arterial pressure, cerebral perfusion pressure, and cerebral venous
O2 saturation in the postinjury period. Cerebral O2 extraction ratios and cerebral venous lactate levels were significantly higher in the ethanol group. A trend toward lower postinjury rCBF in all brain regions was observed in the ethanol group.
Conclusion: In this TBI/HS model, ethanol administration decreased survival time, impaired the hemodynamic response, and worsened measures of cerebral tissue perfusion. 相似文献
Methods: A controlled porcine model of combined TBI and HS was evaluated for the effect of ethanol on survival time, hemodynamic function, and cerebral tissue perfusion. Anesthetized swine (17–24 kg) were instrumented, splenectomized, and subjected to fluid percussion TBI with concurrent 25-mL/kg graded hemorrhage over 30 minutes. Two groups were studied: control ( n = 11) and ethanol ( n = 11). Ethanol, 3.5 g/kg intragastric, was given 100 minutes prior to TBI/HS. Systemic and cerebral physiologic and metabolic parameters were monitored for 2 hours without resuscitation. Regional cerebral blood flow (rCBF) and renal blood flow were measured with dye-labeled microspheres. Data were analyzed with 2-sample t-test and repeated-measures ANOVA.
Results: Ethanol levels at the time of injury were 162 ± 68 mg/dL. Average TBI was 2.65 ± 0.35 atm. Survival time was significantly shorter in the ethanol group (60 ± 27 min vs 94 ± 28 min, p = 0.011). The ethanol group had significantly lower mean arterial pressure, cerebral perfusion pressure, and cerebral venous
O
Conclusion: In this TBI/HS model, ethanol administration decreased survival time, impaired the hemodynamic response, and worsened measures of cerebral tissue perfusion. 相似文献